Millendo Therapeutics' Reverse Merger Round

Millendo Therapeutics raised a round of funding on December 07, 2018. Investors include OvaScience.

Millendo Therapeutics, previously known as Atterocor, is a drug development company focused on a treatment for adrenal cancer. The company seeks to develop adrenal-targeting therapy for the treatment …

Articles about Millendo Therapeutics' Reverse Merger Round: